Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Conditions: Peripheral T-cell Lymphomas; Lymphoproliferative Disorders; Immune System Diseases Interventions: Drug: IOC; Drug: GVHD prophylaxis; Drug: RIC; Procedure: allo HCT Sponsor: National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials